IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Manufacturing Strategies for Generics and Branded Drugs Converge

12:19 PM MDT | September 21, 2007 |

Alex Scott

Generic drugs manufacturers and manufacturers of branded drugs are reassessing their manufacturing strategies in light of tightening competition in the sector, according to a recent report by Enrico T. Polastro, v.p. and senior industry specialist for Arthur D. Little Benelux (Brussels). Typically, generic drugs manufacturers outsource their bulk manufacturing, while branded drugs producers have retained much of their manufacturing in-house. The two distinct models are now converging as producers attempt to gain competitive edge through enhanced bulk ingredients...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa